RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)
$34.18 -0.04 (-0.1169%)
Analysed RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) News Sources
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
01-04-2026
yahoo.com
All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy
26-03-2026
yahoo.com
How Investors May Respond To Rapport Therapeutics (RAPP) Licensing RAP-219 To Tenacia In Greater China
21-03-2026
yahoo.com
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
16-03-2026
fool.com
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
16-03-2026
fool.com
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
16-03-2026
fool.com
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
10-03-2026
yahoo.com
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
09-03-2026
yahoo.com
Rapport Therapeutics to Participate in Upcoming Investor Conferences
24-02-2026
yahoo.com
We're Not Very Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn Rate
18-02-2026
yahoo.com
What is the current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The current price of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is $34.18.
RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) absolute price change since previous trading day?
The absolute price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is $-0.04.
RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) percentage price change since previous trading day?
The percentage price change of RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) since the previous trading day is -0.1169%.
What is the most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The most recent average sentiment score for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)?
The most recent sentiment for RAPPORT THERAPEUTICS INC (RAPP:NASDAQ) is .
SEC-8K** Filing Available For RAPPORT THERAPEUTICS INC (RAPP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.